By proceeding, you agree to our Terms of Use and Privacy Policy.
Chinook Therapeutics (Nasdaq: KDNY) is a clinical-stage biotechnology company developing precision medicines for kidney diseases.
04-06 October 2022
Understand Disease Pathogenesis to Advance Genetic Targets & Technologies Identify Disease Specific Biomarkers of Progression & Therapeutic Efficacy Confidently Recruit Patients & Execute Innovative Clinical Trials in Orphan Disease Populations A new
Event Ended
USA
Paid
Boston
12-14 September 2023
The 3rd Rare & Genetic Kidney Disease Drug Development Summit is a premier industry event dedicated to accelerating the development of therapeutic treatments for rare and genetic kidney diseases such as IgA nephropathy (IgAN), focal segmental glomeru